APA (7th ed.) Citation

De Vita, F., Ventriglia, J., Febbraro, A., Laterza, M. M., Fabozzi, A., Savastano, B., . . . Orditura, M. (2016). NAB-paclitaxel and gemcitabine in metastatic pancreatic ductal adenocarcinoma (PDAC): From clinical trials to clinical practice. BMC Cancer, 16, 1. https://doi.org/10.1186/s12885-016-2671-9

Chicago Style (17th ed.) Citation

De Vita, Ferdinando, et al. "NAB-paclitaxel and Gemcitabine in Metastatic Pancreatic Ductal Adenocarcinoma (PDAC): From Clinical Trials to Clinical Practice." BMC Cancer 16 (2016): 1. https://doi.org/10.1186/s12885-016-2671-9.

MLA (9th ed.) Citation

De Vita, Ferdinando, et al. "NAB-paclitaxel and Gemcitabine in Metastatic Pancreatic Ductal Adenocarcinoma (PDAC): From Clinical Trials to Clinical Practice." BMC Cancer, vol. 16, 2016, p. 1, https://doi.org/10.1186/s12885-016-2671-9.